Arecor Therapeutics plc (LON:AREC – Get Free Report) fell 1.8% on Wednesday . The stock traded as low as GBX 133.35 ($1.68) and last traded at GBX 135 ($1.70). 6,494 shares changed hands during mid-day trading, a decline of 50% from the average session volume of 12,973 shares. The stock had previously closed at GBX 137.50 ($1.73).
Arecor Therapeutics Trading Up 0.9 %
The business has a 50 day moving average price of GBX 137.75 and a 200-day moving average price of GBX 162.51. The firm has a market cap of £41.70 million, a price-to-earnings ratio of -435.48 and a beta of -0.22. The company has a quick ratio of 6.24, a current ratio of 2.52 and a debt-to-equity ratio of 1.26.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- High Flyers: 3 Natural Gas Stocks for March 2022
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Using the MarketBeat Stock Split Calculator
- Generac Powers Ahead on the Electrification Mega-Trend
- 3 Warren Buffett Stocks to Buy Now
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
